Archive for the ‘Trius Therapeutics Inc’ Category

Trius Therapeutics Inc

September 7th, 2010 | Posted in Trius Therapeutics Inc

Trius Therapeutics Inc hs begun a Phase 3 Clinical Study of the oral dosage form of torezolid phosphate for the treatment of acute bacterial skin and skin structure infections.